K. Gordon

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa

J. Mellors, C. Brumme, C. Wallis, 2018, Antiviral chemistry & chemotherapy.

HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial

J. Baeten, D. Szydlo, J. Mellors, 2021, Journal of the International AIDS Society.

Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa

J. Mellors, P. Harrigan, C. Brumme, 2016, Antimicrobial Agents and Chemotherapy.